From: Safety and efficacy of precision hepatectomy in the treatment of primary liver cancer
Indicators | Time | Study group(49) | Control group(49) | t | P |
---|---|---|---|---|---|
AST(U/L) | Before surgery | 58.92 ± 7.76 | 58.68 ± 7.89 | 0.152 | 0.881 |
1 week after surgery | 41.38 ± 6.37 | 34.98 ± 6.74 | 4.831 | <0.001 | |
TBiL(U/L) | Before surgery | 31.87 ± 5.91 | 32.09 ± 5.65 | -0.188 | 0.851 |
1 week after surgery | 17.47 ± 5.12 | 14.39 ± 5.09 | 2.986 | 0.002 | |
ALT(U/L) | Before surgery | 46.76 ± 4.92 | 45.69 ± 5.01 | 1.067 | 0.289 |
1 week after surgery | 32.81 ± 5.37 | 26.98 ± 5.48 | 5.319 | <0.001 | |
ALB(U/L) | Before surgery | 38.71 ± 5.81 | 38.65 ± 6.09 | 0.051 | 0.961 |
1 week after surgery | 55.39 ± 6.01 | 46.19 ± 6.06 | 7.546 | <0.001 |